Breaking News
Investing Pro 0
Last Call for Cyber Monday! Save Now on Claim 60% OFF

BeiGene fetches new 'buy' rating at Jefferies

Published Aug 17, 2023 17:28
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
BGNE
+0.29%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NOVN
+0.31%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMGN
+1.04%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Equity research firm Jefferies initiated coverage on BeiGene (NASDAQ:BGNE) with a "buy" rating and a price target of $287. BeiGene is an oncology company with a strong presence in China, and Jefferies sees it as an R&D "powerhouse" with a rich portfolio of treatments for tumors.

Jefferies noted that BeiGene has a unique business model combining advantages of its strong China presence and global commercial network to innovate with speed and quality at low cost. Jefferies analysts also noted the best-in-class potential of BTK inhibitor BRUKINSA and tislelizumab's leading position in the PD-1 market in China.

The analysts explained, “BGNE is an oncology-focused China-originated company featured by its R&D powerhouse and global commercial networks, which are showcased by best-in-class BTK inhibitor BRUKINSA poised to excel in $10B+ global market and tislelizumab's leading position in a competitive PD-1 market in China. A deep and broad pipeline will sustain long-term growth, and strategic partners Novartis and Amgen should further extend BGNE's global reach.”

BeiGene has a market cap of around $20 billion, and the stock trades at just over $190 per share. At least 15 Wall Street analysts have a buy or buy-equivalent rating on the stock, but shares are down by over 10% this year.

BeiGene fetches new 'buy' rating at Jefferies
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email